You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • FRI0037 Results of a pivotal (phase iii) placebo and active comparator controlled efficacy trial of rofecoxib 25 and 50 mg in adult patients with rheumatoid arthritis (ra)

Citation Tools

Article menu
Download PDFPDF
Speaker abstracts 2001
Rheumatoid Arthritis – Treatment
FRI0037 Results of a pivotal (phase iii) placebo and active comparator controlled efficacy trial of rofecoxib 25 and 50 mg in adult patients with rheumatoid arthritis (ra)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Truitt K, Guesens P, DeTora L, et al
FRI0037 Results of a pivotal (phase iii) placebo and active comparator controlled efficacy trial of rofecoxib 25 and 50 mg in adult patients with rheumatoid arthritis (ra)
Annals of the Rheumatic Diseases 2001;60:A460.